June 09, 2014 Intelligence: Late-Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

Inpatient utilization has declined in Boston, Indianapolis, and Newark. That’s the finding of a new report issued May 27 by Kaufman Hall, a consulting firm based in Skokie, Illinois. The data was collected by Tufts Medical Center in Boston; Barnabas Health in West Orange, New Jersey; and Community Health Network in Indianapolis. For the 2010-2012 period, inpatient utilization dropped among most age groups and service lines in these three metropolitan areas. Kaufman Hall said “the studies show a broad-based transition underway from an inpatient-focused to an outpatient-focused healthcare system.”

MORE ON: Inpatient

For nine counties in Eastern Massachusetts, overall inpatient utilization declined 5% (and 10% for patients 65 and older). Newark’s inpatient utilization decline was 4.3% (and 10.2% for the 65-74 year old cohort). The nine-county area around Indianapolis saw a 2.5% drop in inpatient utilization (and just a 0.4% decline for patients 65 and older). Kenneth Kaufman, Chair of Kaufman Hall, noted that, “These findings are further evidence that markets around the country are reaching an inflection point in the shift from inpatient to outpatient orientation.”

SPENDING GROWTH IN HEALTHCARE IT

Most pathologists and lab managers know that one of the hottest growth sectors in healthcare is information technology (IT), but few people know exactly how much is spent each year on these IT systems. A recently-released report by Transparency Market Research of Albany, New York, estimates that global spending on healthcare IT was $35.1 billion in 2013. In the report, titled “Healthcare Information System Market, ” the research firm also predicts that, by 2019, such spending worldwide will reach $53.2 billion annually. That is a compound average growth rate of 7.1% between 2013 and 2019.

TRANSITIONS

  • Donald Steen, 67, of Dallas, Texas, died of complications from leukemia on May 13. A CPA, Steen was the Chairman and CEO of AmeriPath, Inc. from 2004 until 2007, at the time when AmeriPath was acquired by Quest Diagnostics Incorporated. He held executive positions at Welsh, Carson, Anderson & Stowe, United Surgical Partners International Inc., Columbia/HCA Healthcare Corporation, and Medical Care America, Inc.

Dark Daily Update

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about…

…advances in using cell phones to perform coagulation tests that were achieved by researchers at the Swiss Federal Institute of Technology. Their goal is to help patients on anticoagulants manage their dosages.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com

Comments

Leave a Reply